Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
Retatrutide is the developmental designation for an investigational compound owned by Eli Lilly and Company
Dose-dependent reductions in A1C and body weight at higher doses in people with type 2 diabetes have been demonstrated in the phase 2 evaluation of oral semaglutide, suggesting that oral semaglutide at higher doses may provide a more individualized treatment option in people with type 2 diabetes who need additional glycemic control and/or additional weight reduction, explained Sue Pedersen, MD, FRCPC, Specialist in Endocrinology and Metabolism at C-ENDO Diabetes & Endocrinology Clinic, Calgary, Canada
While the list price of $1,300 a month is floated a lot, thats not the amount drug companies charge much of the time
Contact us today to book your appointment and start your Semaglutide journey
If dosing is too high or continuous without breaks, the body will downregulate its own endogenous pathways and could become dependent or have blunted natural hormone production
US$ 26.06
US$ 20.05
US$ 25.96
US$ 22.67
US$ 23.95
